Cipla Ltd.

Cipla has received Establishment Inspection Report (EIR) from US Food & Drug Administration (USFDA) for Goa manufacturing facility. The inspection was carried out by USFDA from January 26, 2019 to January 28, 2019.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. The company’s portfolio includes over 1500 products across wide range of therapeutic categories with one quality standard globally.